Bioorganic models for transmembrane proteins

跨膜蛋白的生物有机模型

基本信息

  • 批准号:
    7031985
  • 负责人:
  • 金额:
    $ 28.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-12-01 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Since Anfinsen's demonstration that the sequence of a protein dictates its structure, the energetics and kinetics of folding have been explored with ever-greater temporal and spatial resolution. However, almost all of these studies have been devoted to water-soluble proteins, and our understanding of membrane proteins is in its infancy. Here, we use protein design to test and refine our understanding of membrane protein folding. Model peptides are designed to associate into helical bundles in micelles and phospholipid bilayers. The study of these systems is simplified by the fact that the unfolded state is well defined (the monomeric helices), and the energetics of folding can be monitored by measuring the monomer-nmer equilibrium. In aims 1 & 2, we test the importance and relative energetic contributions of disparate forces such as van der Waals packing versus polar interactions. These studies will not only further our understanding of protein folding, but also provide insight and methods to understand the process of transmembrane helix association, which often plays an essential role in signal transduction. As an outgrowth of our understanding of the folding of membrane proteins, we are beginning to design water-soluble versions of 2 membrane proteins, phospholamban and the KcsA potassium channel. These studies promise to provide a new method for obtaining large quantities of water-soluble versions of membrane proteins for pharmaceutical and biophysical studies. Our specific aims are as follows: Aim 1. We will study the association of designed and natural transmembrane peptides, and use these systems to understand the features leading to the folding and association of transmembrane helices. Aim 2. We will explore how regions of a protein located in the aqueous, headgroup, and membrane interior cooperate to dictate the fold of a protein by designing helical bundles that incorporate both transmembrane as well as water-soluble folding motifs. Aim 3 We will structurally characterize water-soluble versions of phospholamban and KcsA. Aim4. We will develop computational methods for transmembrane protein structure prediction & design.
描述(由申请人提供):自从Anfinsen证明蛋白质的序列决定其结构以来,已经以更高的时间和空间分辨率探索了折叠的能量学和动力学。然而,几乎所有这些研究都致力于水溶性蛋白质,我们对膜蛋白的理解还处于起步阶段。在这里,我们使用蛋白质设计来测试和完善我们对膜蛋白折叠的理解。模型肽被设计成在胶束和磷脂双层中缔合成螺旋束。这些系统的研究被简化的事实,即未折叠状态是明确定义的(单体螺旋),折叠的能量学可以通过测量单体-单体平衡来监测。在目标1和2中,我们测试了不同力的重要性和相对能量贡献,例如货车德瓦尔斯堆积与极性相互作用。这些研究不仅将进一步加深我们对蛋白质折叠的理解,而且还为理解跨膜螺旋缔合过程提供了见解和方法,跨膜螺旋缔合通常在信号转导中起着重要作用。作为我们对膜蛋白折叠的理解的产物,我们开始设计2种膜蛋白的水溶性版本,受磷蛋白和KcsA钾通道。这些研究有望提供一种新的方法,获得大量的水溶性版本的膜蛋白的药物和生物物理研究。我们的具体目标如下:目标1。我们将研究设计和天然跨膜肽的关联,并使用这些系统来了解导致跨膜螺旋折叠和关联的特征。目标2.我们将探讨如何在水,头基,和膜内部的蛋白质的区域合作,通过设计的螺旋束,将跨膜以及水溶性折叠基序来决定蛋白质的折叠。目的3我们将在结构上表征水溶性形式的受磷蛋白和KcsA。目标4。 我们将发展跨膜蛋白质结构预测和设计的计算方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM DEGRADO其他文献

WILLIAM DEGRADO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM DEGRADO', 18)}}的其他基金

Targeting Viroporins and Coronavirus M Protein
靶向病毒孔蛋白和冠状病毒 M 蛋白
  • 批准号:
    10512629
  • 财政年份:
    2022
  • 资助金额:
    $ 28.66万
  • 项目类别:
Deciphering the relationship between structure, dynamics and function in helical bundle proteins
解读螺旋束蛋白的结构、动力学和功能之间的关系
  • 批准号:
    10703499
  • 财政年份:
    2017
  • 资助金额:
    $ 28.66万
  • 项目类别:
Deciphering the relationship between structure, dynamics and function in helical bundle proteins
解读螺旋束蛋白的结构、动力学和功能之间的关系
  • 批准号:
    10172923
  • 财政年份:
    2017
  • 资助金额:
    $ 28.66万
  • 项目类别:
Deciphering the relationship between structure, dynamics and function in helical bundle proteins
解读螺旋束蛋白的结构、动力学和功能之间的关系
  • 批准号:
    10406742
  • 财政年份:
    2017
  • 资助金额:
    $ 28.66万
  • 项目类别:
Deciphering the relationship between structure, dynamics and function in helical bundle proteins
解读螺旋束蛋白的结构、动力学和功能之间的关系
  • 批准号:
    9977222
  • 财政年份:
    2017
  • 资助金额:
    $ 28.66万
  • 项目类别:
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.
用整合素αvβ1抑制剂治疗肺纤维化。
  • 批准号:
    8931040
  • 财政年份:
    2014
  • 资助金额:
    $ 28.66万
  • 项目类别:
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.
用整合素αvβ1抑制剂治疗肺纤维化。
  • 批准号:
    9144901
  • 财政年份:
    2014
  • 资助金额:
    $ 28.66万
  • 项目类别:
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.
用整合素αvβ1抑制剂治疗肺纤维化。
  • 批准号:
    9310063
  • 财政年份:
    2014
  • 资助金额:
    $ 28.66万
  • 项目类别:
Treatment of pulmonary fibrosis with inhibitors of integrin alphavbeta1.
用整合素αvβ1抑制剂治疗肺纤维化。
  • 批准号:
    8748498
  • 财政年份:
    2014
  • 资助金额:
    $ 28.66万
  • 项目类别:
Vaccines that Replicate the Neutralization-Competent Structure of the gp41 MPER
复制 gp41 MPER 中和能力结构的疫苗
  • 批准号:
    8263672
  • 财政年份:
    2012
  • 资助金额:
    $ 28.66万
  • 项目类别:

相似海外基金

Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
  • 批准号:
    10557547
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Mitochondrial positioning regulates redox-signaling during cell migration
线粒体定位调节细胞迁移过程中的氧化还原信号
  • 批准号:
    10520211
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Ceramides as Novel Mediators of Tubular Metabolic Dysfunction Driving Kidney Injury
神经酰胺作为肾小管代谢功能障碍驱动肾损伤的新型调节剂
  • 批准号:
    10677394
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Energizing and Protecting Axons Through Metabolic Coupling to Schwann Cells
通过与雪旺细胞的代谢耦合来激活和保护轴突
  • 批准号:
    10647707
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Circadian and mitochondrial dysfunction in alcohol-related liver disease
酒精相关性肝病中的昼夜节律和线粒体功能障碍
  • 批准号:
    10667861
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Neuronal ABCA7 loss of function and Alzheimer’s disease
神经元 ABCA7 功能丧失与阿尔茨海默病
  • 批准号:
    10629715
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
  • 批准号:
    10643012
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
  • 批准号:
    10734403
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
High subzero preservation of liver for transplantation
移植用肝脏的高度低温保存
  • 批准号:
    10815970
  • 财政年份:
    2023
  • 资助金额:
    $ 28.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了